Cathepsin B in the Growth of Colorectal Cancer: Suppressive Effect of Leupeptin on the Growth of DMH-induced Rat Colon Neoplasm

Acta Medica Okayama

Volumn 50, Issue 6, 1996, Pages 299-303

  Satoh, Yasumasa ^a   Higashi, Toshihiro ^a   Nouso, Kazuhiro ^a   Shiota, Tetsuya ^a   Kinugasa, Nobuyuki ^a   Yoshida, Keigo ^a   Uematsu, Shuji ^a   Nakatsukasa, Harushige ^a   Nishimura, Yukio ^b   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cathepsin B; Protease inhibitor; Rat colon neoplasm

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CAMOSTAT MESILATE; CARCINOGEN; CATHEPSIN B; DIMETHYLHYDRAZINE; DRUG DERIVATIVE; GABEXATE; GUANIDINE DERIVATIVE; LEUPEPTIN; PROTEINASE INHIBITOR;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COLON TUMOR; ENZYMOLOGY; MALE; METABOLISM; PATHOLOGY; RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; CARCINOGENS; CATHEPSIN B; COLONIC NEOPLASMS; DIMETHYLHYDRAZINES; GABEXATE; GUANIDINES; LEUPEPTINS; MALE; PROTEASE INHIBITORS; RATS;

EID: 0030341917     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sloane BF, Dunn JR and Honn KV: Lysosomal cathepsin B: Correlation with metastatic potential. Science (1981) 212, 1151-1153.
2. Sloane BF, Moin K, Krepela E and Rozhin J: Cathepsin B and its endogenous inhibitors: The role in tumor malignancy. Cancer Metastasis Rev (1990) 9, 333-352.
3. Rempel SA, Mikkelsen RML, Yan P-S, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G and Sloane BF: Cathepsin B expression and localization in glioma progression and invasion. Cancer Res (1994) 54, 6027-6031.
4. Murnane MJ, Sheahan K, Ozdemiri M and Shuja S: Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res (1991) 51, 1137-1142.
5. Weiss RE, Liu BCS, Ahlering T, Dubeau L and Droller MJ: Mechanisms of human bladder tumor invasion: Role of proteases cathepsin B. J Urol (1990) 144, 798-804.
6. Inoue T, Sugio K and Sugimachi K: Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res (1994) 1994, 6133-6136.
7. Watanabe N, Higashi T, Hashimoto M, Tomoda I, Tominaga S, Hashimoto N, Morimoto S, Yamauchi Y, Nakatsukasa H, Kobayashi M, Watanabe A and Nagashima H: Elevation of tissue cathepsin B and L activities in gastric cancer. Hepato-Gastroenterology (1987) 34, 120-122.
8. Watanabe M, Higashi T, Watanabe A, Osawa T, Sato Y, Kimura Y, Tominaga S, Hashimoto N, Yoshida Y, Morimoto S, Shiota T, Hashimoto M, Kobayashi M, Tomoda J and Tsuji T: Cathepsin B and L activities in gastric cancer: Correlation with histological findings. Biochem Med Metabol Biol (1989) 42, 21-29.
9. Satoh Y, Higashi T, Nouso K, Shiota T, Kinugasa N, Yoshida K, Uematsu S, Nakatsukasa H, Nishimura Y and Tsuji T: Cathepsin B in the growth of colorectal cancer: Increased activity of cathepsin B in human colorectal cancer. Acta Med Okayama (1996) 50, 305-311.
10. Hozumi M, Ogawa M, Sugimura T, Takeuchi T and Umezawa H: Inhibition of tumorigenesis in mouse skin by leupeptin, a protease inhibitor from Actinomycetes. Cancer Res (1972) 32, 1725-1728.
11. Kakizoe T, Esumi H, Kawachi T, Sugimura T, Takeuchi T and Umezawa H: Further studies on the effect of leupeptin, a protease inhibitor, on induction of bladder tumors in rats by N-butyl-N-(4-hydroxybutyl) nitrosamine. J Natl Cancer Inst (1977) 59, 1503-1508.
12. Lhoste EF, Roebuck BD and Longnecker DS: Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Carcinogenesis (1988) 9, 901-906.
13. Yamamoto RS, Umezawa H, Takeuchi T, Matsushima T, Hara K and Sugimura T: Effect of leupeptin on colon carcinogenesis in rats with azoxymethane. Proc Am Assoc Cancer Res (1974) 15, 38.
14. Aoyagi T, Nanbo M, Kojima F, Matsuzaki M, Ishizuka M, Takeuchi T and Umezawa H: Biological activities of leupeptin. J Antibiot (Tokyo) (1969) 22, 558-568.
15. Camiolo SM and Greco WR: Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assay. Cancer Res (1986) 46, 1788-1794.
16. Kohga S, Harvey SR, Weaver RM and Markus G: Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res (1985) 45, 1787-1796.
17. Ohkoshi M and Fujii S: Effect of the synthetic proteases inhibitor (N, N-dimethylcarbomyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate) methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin. J Natl Cancer Inst (1983) 71, 1053-1057.
18. Reddy BS, Narisawa T, Vukusich D, Weisberger JH and Wynder EL: Effect of quality and quantity of dietary fat and dimethylhydrazine in colon carcinogenesis in rats. Proc Soc Exp Biol Med (1976) 151, 237-239.
19. Pozharisski KM: Morphology and morphogenesis of experimental epithelial tumors of the intestine. J Natl Cancer Inst (1975) 54, 1115-1123.
20. Higashi T, Hashimoto M, Watanabe M, Yamauchi Y, Fujiwara M, Nakatsukasa H, Kobayashi M, Watanabe A and Nagashima H: Assay procedures for cathepsin B, H and L activities in rat tissue homogenates. Acta Med Okayama (1986) 40, 27-32.
21. Lowry OH, Rosebrough NJ, Fare AL and Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem (1951) 193, 265-275.
22. Fearon ER and Vogelstein B: A genetic model for colorectal tumorgenesis. Cell (1990) 61, 759-767.
23. Shuja S, Sheahan K and Murnane MJ: Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas, Int J Cancer (1991) 49, 341-346.
24. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane BF and Emmer-Buck MR: Cathepsin B expression in colorectal carcinoma correlates with tumor progression and shortened patient survival. Am J Pathol (1994) 145, 301-309.
25. Rozhin J, Gomez AP, Ziegler GH, Nelson KK, Chang YS, Fong D, Onoda JM, Honn KV and Sloane BF: Cathepsin B to cysteine protease inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res (1990) 50, 6278-6284.